RxDoctor Payments Data

Jack Vu

Family Medicine · Long Beach, CANPI 1083885826

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,859 of the $2,105 with a category attached, or 88.3%. Eli Lilly accounts for 98.3% of it on its own, with 1 other manufacturer making up the rest.

$2,105in general payments, 2019–2025

Across 13 payments — averaging $161.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Aimmune Therapeutics, Inc.$36
$10,400,197in research payments, 2019–2025

Across 2,754 payments — averaging $3776.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$5.1M
  • Eli Lilly$1.4M
  • Janssen Research & Development, LLC$1.3M
  • Pfizer$803K
  • Amgen$455K
  • Roche Diagnostics Operations, Inc.$393K
  • plus $888K from 13 others

What the payments were for

  • Travel & lodging$1,85988%
  • Food & beverage$24612%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly11$2,069
Aimmune Therapeutics, Inc.2$36

How this compares

$2,105 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Other family medicine in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →